FDA says it explained issues early on for Corcept’s rejected Cushing’s syndrome drugnews2026-01-30T19:14:25+00:00January 30th, 2026|Endpoints News|
CHMP opposes Lilly’s Mounjaro in heart failure, backs Novo’s Kayshildnews2026-01-30T17:18:18+00:00January 30th, 2026|Endpoints News|
Ultragenyx resubmits gene therapy for rare neuro disease to FDAnews2026-01-30T16:50:40+00:00January 30th, 2026|Endpoints News|
Summit gets November PDUFA date for its PD-1xVEGF bispecificnews2026-01-29T15:07:25+00:00January 29th, 2026|Endpoints News|
Tenpoint gets FDA nod for presbyopia eye drop and $235Mnews2026-01-29T06:08:04+00:00January 29th, 2026|Endpoints News|
FDA asks court to pause Louisiana’s abortion pill fightnews2026-01-28T19:18:46+00:00January 28th, 2026|Endpoints News|
FDA suspends two Regenxbio gene therapy trials after patient developed brain tumornews2026-01-28T15:56:29+00:00January 28th, 2026|Endpoints News|
HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launchnews2026-01-28T15:26:09+00:00January 28th, 2026|Endpoints News|
FDA lifts hold on one of two Phase 3 gene editing studies by Intellianews2026-01-27T15:52:33+00:00January 27th, 2026|Endpoints News|
ACIP members depict diverging goals after schedule changenews2026-01-23T18:24:41+00:00January 23rd, 2026|Endpoints News|
